icon-folder.gif   Conference Reports for NATAP  
 
  63rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 9-12 2012
Back grey_arrow_rt.gif
 
 
 
First Report of Peginterferon Lambda/Ribavirin in Combination With Either Daclatasvir or Asunaprevir in HCV Genotype 1 Japanese Patients: Early Sustained Virologic Response (SVR4) Results From the D-LITE Japanese Substudy
 
 
  Reported by Jules Levin
AASLD
Nov 9-13 2012 Boston
 
Izumi N,1 Lataillade M,2 Chayama K,3 Toyota J,4 Mochida S,5 Kawada N,6 Ishikawa H,7 Hosokawa E,7 Imai J,7 Scricca R,2 Cohen D,2 Xu D,2 Horga M,2 Yogaratnam J,2 Srinivasan S,2 Kumada H,8 Lopez-Talavera J-C2 for the D-LITE study team 1Musashino-Red Cross Hospital, Tokyo, Japan; 2Bristol-Myers Squibb Research and Development, Wallingford, CT; 3Hiroshima University Hospital, Hiroshima, Japan; 4Sapporo-Kosei General Hospital; 5Saitama Medical University Hospital, Saitama, Japan; 6Osaka City University Hospital; 7Bristol-Myers KK, Tokyo, Japan; 8Toranomon Hospital, Kawasaki, Japan

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

CumWeek4.gif